The new systems offer the pharmaceutical industry uniquely powerful tools for the rapid, automated component-specific measurement of particle size, shape and chemical identification
Malvern Panalytical wins Innovate UK grant to lead biopharmaceutical consortium on aggregation analytics
Microcalorimetry enables detailed investigation of the interactions between and thermodynamics of molecules/biomolecules and is particularly widely used in the development and manufacture of biopharmaceuticals
Malvern Instruments has released new guidance on using automated image analysis to detect and quantify agglomerates. The ability of uncontrolled agglomeration to substantially impact the performance and value of powder products makes efficient agglomerate detection vital across a number of industries.
Taking the example of Malvern’s development of the Mastersizer 3000 particle size analyzer, the authors illustrate how instrument companies are aligning with the QbD philosophy.
Malvern Instruments Ltd (Malvern, UK) has today (July 25) announced that it has completed the acquisition of MicroCal from GE Healthcare Life Sciences and has also purchased the Archimedes particle characterization system from Affinity Biosensors LLC (Santa Barbara, CA). Both of these developments extend Malvern’s portfolio of analytical solutions for the rapidly advancing biopharmaceutical industry.
Malvern Instruments Ltd. (Malvern, UK) announced today (June 4) that it has entered into an agreement with GE Healthcare Life Sciences to acquire the company’s MicroCal™ microcalorimetry business. Financial terms were not disclosed. The acquisition, which is subject to regulatory approvals, is expected to complete in the third quarter of 2014.